suppressor of cytokine signaling 3
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein ubiquitination | ||
| cytokine-mediated signaling pathway | ||
| intracellular signal transduction | ||
| negative regulation of apoptotic process | ||
| positive regulation of cell differentiation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytosol | ||
| cytoplasmic side of plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| phosphotyrosine residue binding | ||
| protein kinase inhibitor activity | ||
| cytokine receptor binding | ||
| protein binding | ||
| protein tyrosine kinase inhibitor activity |
| Gene Ontology |
|---|
| 1-phosphatidylinositol-3-kinase regulator activity |
| protein ubiquitination |
| InterPro |
|---|
| SH2 domain superfamily |
| SH2 domain |
| SOCS box domain |
| SOCS box-like domain superfamily |
| SOCS3, SH2 domain |
| Suppressor of cytokine signalling 3, SOCS box domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:9970 | obesity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026